Lobbying Filing Details

Total Spending

$440,000

Activities

3

Lobbyists

1

Gov't Entities

6

Filing Information
Filing UUID:
bec4e0ed-f1a4-4cc0-9bf8-f5b4afe265a6
Type:
Q1 - 1st Quarter - Report
Period:
2025 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 18, 2025 at 4:27 PM
Income:
$0
Expenses:
$440,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Michael Mattoon, Vice President, Government Affairs & Policy - Acadia Pharmaceuticals
Registrant
ACADIA PHARMACEUTICALS

Biopharmaceutical company

San Diego, California
Client
ACADIA PHARMACEUTICALS
California, United States of America
Lobbying Activities (3)
Activity 1
Health Issues

Implementation of the Inflation Reduction Act of 2022; Orphan Cures Act (HR 946); National Plan to End Parkinsons Act (Public Law 118-66, 118th Congress); Give Kids A Chance (HR1262); Cameron's Law (HR1414).

Lobbyists (1)
  • MR. MICHAEL MATTOON
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Medicare/Medicaid

Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues related to Antipsychotic use in Medicare; Orphan Cures Act (HR 946); National Plan to End Parkinsons Act (Public Law 118-66, 118th Congress); EPIC Act (HR 1492).

Lobbyists (1)
  • MR. MICHAEL MATTOON
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Taxation/Internal Revenue Code

Cameron's Law (HR 14114)

Lobbyists (1)
  • MR. MICHAEL MATTOON
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 11, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.